U.S. markets closed
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • Dow 30

    34,265.37
    -450.02 (-1.30%)
     
  • Nasdaq

    13,768.92
    -385.10 (-2.72%)
     
  • Russell 2000

    1,987.92
    -36.12 (-1.78%)
     
  • Crude Oil

    84.83
    -0.72 (-0.84%)
     
  • Gold

    1,836.10
    -6.50 (-0.35%)
     
  • Silver

    24.34
    -0.37 (-1.50%)
     
  • EUR/USD

    1.1348
    +0.0031 (+0.27%)
     
  • 10-Yr Bond

    1.7470
    -0.0860 (-4.69%)
     
  • GBP/USD

    1.3555
    -0.0045 (-0.33%)
     
  • USD/JPY

    113.6500
    -0.4500 (-0.39%)
     
  • BTC-USD

    34,939.61
    -1,650.51 (-4.51%)
     
  • CMC Crypto 200

    870.86
    +628.18 (+258.85%)
     
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • Nikkei 225

    27,522.26
    -250.67 (-0.90%)
     
  • Oops!
    Something went wrong.
    Please try again later.

DexCom: 4Q Earnings Snapshot

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • DXCM

SAN DIEGO (AP) _ DexCom Inc. (DXCM) on Thursday reported fourth-quarter net income of $92.7 million, after reporting a loss in the same period a year earlier.

The San Diego-based company said it had profit of $1 per share. Earnings, adjusted for non-recurring costs and amortization costs, were $1.15 per share.

The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 75 cents per share.

The medical device company posted revenue of $462.8 million in the period.

For the year, the company reported net income of $101.1 million, or $1.10 per share, swinging to a profit in the period. Revenue was reported as $1.48 billion.

DexCom expects full-year revenue in the range of $1.73 billion to $1.78 billion.

DexCom shares have increased 15% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $252.21, an increase of 69% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DXCM at https://www.zacks.com/ap/DXCM